Estela Carvalho
Research member of ElectroBio project
MSc in Biophysics and Bionanosystems
Degree in Genetic and Biotechnology
This email address is being protected from spambots. You need JavaScript enabled to view it.
This email address is being protected from spambots. You need JavaScript enabled to view it. https://orcid.org/0000-0002-6110-9814
Current Project
Development of electroactive materials with different morphologies for biological applications
Electroactive materials influence on biological response of specific cells such as fibroblast and osteoblast are already known. In the present work, the development of electroactive materials with different morphologies will be focused. Novel architectures – inks, spheres, films and scaffolds – will be performed as active substrates to proliferation and differentiation cell assays. Thus, the acquired knowledge will be transferred to others biological entities: bacteria. A gram-negative and a gram-positive strain will be used to evaluate the capability of these materials to promote or inhibit biofilm formation.
Pedro Manuel Martins
Research member of ENMed project
Ph.D. in Physics
MSc in Micro/Nanotechnologies
Degree in Applied Biology
This email address is being protected from spambots. You need JavaScript enabled to view it.
This email address is being protected from spambots. You need JavaScript enabled to view it. https://orcid.org/0000-0001-8179-8242
Current Project
Multiplex point-of-care device for lung disease biomarkers in sputum
This work is dedicated to "Making a microfluidic platform." This platform will have several sub-components (sampling area, reference zone, detection zone) that require optimization. The platform must take into account the location of the electrodes of the biomarkers measurement transducers.
Paper will be used as a substrate for the development of the microfluidic platform and inks applied by ink-jet printing or screen printing for the manufacture of the components, which will also be developed and optimized.
The work also comprises the "Inclusion of the biocomponents and tests in the microfluidic platform" to verify and optimize the microfluidic flow in the detection zones.
